col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Informa UK (Taylor & Francis): Leukemia & Lymphoma
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―27 Between a rock and a hard place: COVID-19 vaccination and patients on rituximab therapy Benjamin W. Teh, Constantine S. Tam
2 [GO] 2021―Jul―22 Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group Tomás Palanques-Pastor, Juan Eduardo Megías-Vericat, Pilar Martínez, José Luis López Lorenzo, Javier Cornago Navascués, Gabriela Rodriguez Macias, et al. (+37)
3 [GO] 2021―Jul―15 Systematic screening for SARS-CoV-2 in patients with hematological malignancies on active anticancer treatment in the outpatient setting Marzia Varettoni, Silvia Mangiacavalli, Sara Rattotti, Claudio Salvatore Cartia, Chiara Cavalloni, Franca Rossetti, et al. (+13)
4 [GO] 2021―Jul―13 COVID-19 in chronic myeloid leukemia patients in Latin America Katia B. Pagnano, Evelyn Herrera Peralta, Juan Ramon Navarro, Lourdes del Rosario David Salas, Nancy Delgado, Beatriz Moiraghi, et al. (+23)
5 [GO] 2021―Jun―28 Neutropenia in adult acute myeloid leukemia patients represents a powerful risk factor for COVID-19 related mortality Maximilian Stahl, Varun Narendra, Justin Jee, Andriy Derkach, Molly Maloy, Mark B. Geyer, et al. (+6)
6 [GO] 2021―Jun―24 Impact of COVID-19 on peripheral blood stem cell mobilization for myeloma patients Marquita Camilleri, Thomas McGrath, William Wilson, Stuart J. Ings, Jacqueline Horder, Fiona Newrick, et al. (+6)
7 [GO] 2021―Jun―21 COVID-19 vaccination in patients on rituximab: a survey of lymphoma physicians at NCI designated cancer centers Marcus Messmer, Nina Wagner-Johnston
8 [GO] 2021―May―11 Recurrence of primary cutaneous CD30-positive lymphoproliferative disorder following COVID-19 vaccination Caitlin M. Brumfiel, Meera H. Patel, David J. DiCaudo, Allison C. Rosenthal, Mark R. Pittelkow, Aaron R. Mangold
9 [GO] 2021―Mar―17 Convalescent hyperimmune plasma in patients with hematologic malignancies and severe COVID-19 infections Alain Mina, Sara Small, Leonidas C. Platanias
10 [GO] 2021―Feb―28 Lessons learned for successful treatment of AML in the second wave of COVID-19 outbreak A. Ramírez-López, P. Lázaro del Campo, K. Humala, B. De la Cruz Benito, I. Sánchez-Vadillo, A. López de la Guía, et al. (+3)
11 [GO] 2021―Feb―23 Severe IgA-mediated autoimmune hemolytic anemia triggered by SARS-CoV-2 infection Aude Mausoleo, Soledad Henriquez, Cécile Goujard, Anne-Marie Roque-Afonso, Nicolas Noel, Olivier Lambotte
12 [GO] 2021―Jan―29 Haematological malignancy and nosocomial transmission are associated with an increased risk of death from COVID-19: results of a multi-center UK cohort Talvinder Bhogal, Umair T. Khan, Rebecca Lee, Alexander Stockdale, Christian Hesford, Vaishnav Potti-Dhananjaya, et al. (+17)
13 [GO] 2021―Jan―22 Anemia and red blood cell abnormalities in COVID-19 Philip Murphy, Siobhan Glavey, John Quinn
14 [GO] 2021―Jan―19 Convalescent hyperimmune plasma for chemo-immunotherapy induced immunodeficiency in COVID-19 patients with hematological malignancies Silvia Ferrari, Chiara Caprioli, Alessandra Weber, Alessandro Rambaldi, Federico Lussana
15 [GO] 2021―Jan―10 Severe COVID-19 infection in a patient with paroxysmal nocturnal hemoglobinuria on eculizumab therapy Alexis Genthon, Thibault Chiarabini, Pierre Baylac, Nadia Valin, Tomas Urbina, Jérome Pacanowski, et al. (+7)
16 [GO] 2020―Dec―26 Evolving management strategies for lymphomas during the COVID-19 pandemic Noemie Lang, John Kuruvilla
17 [GO] 2020―Dec―03 COVID-19 in patients with multiple myeloma: a cross-sectional survey from the most severely affected region in China Chunyan Sun, Junying Li, Hang Xiang, Chunrui Li, Anfang Shang, Wei Chang, et al. (+13)
18 [GO] 2020―Nov―10 Outcome of hospitalized patients with hematological malignancies and COVID-19 infection in a large urban healthcare trust in the United Kingdom Catherine Garnett, David Foldes, Chris Bailey, George Nesr, Tracy Hui, Richard Hinton, et al. (+10)
19 [GO] 2020―Sep―09 Efficacy and safety of ruxolitinib for Covid-19 related acute respiratory distress syndrome in a patient with blastic plasmacytoid dendritic cell neoplasm (leukemic variant) Vincenzo Sammartano, Adele Santoni, Bruno Frediani, Anna Sicuranza, Cencini Emanuele, Federico Franchi, et al. (+2)
20 [GO] 2020―Aug―25 Clinical characteristics, therapeutic management, and prognostic factors of adult COVID-19 inpatients with hematological malignancies Yaogong Wu, Wenlan Chen, Wenjing Li, Miaomiao Zhao, Qiuzhe Wei, Xiaoping Zhang, et al. (+3)
21 [GO] 2020―Jul―23 The management of chronic lymphoproliferative disorders at the time of SARS-Covid2 pandemic: weathering the storm Anna Maria Frustaci, Giulia Zamprogna, Marina Deodato, Roberto Cairoli, Marco Montillo, Alessandra Tedeschi
22 [GO] 2020―Jul―09 Hematological manifestations of COVID-19 Alain Mina, Koen van Besien, Leonidas C. Platanias
23 [GO] 2020―Jul―02 Continuous high-dose ivermectin appears to be safe in patients with acute myelogenous leukemia and could inform clinical repurposing for COVID-19 infection Claudio Galvao de Castro Jr., Lauro Jose Gregianin, Jan A. Burger
24 [GO] 2020―Jun―17 SARS-CoV-2 in multiple myeloma: initial observation and management Elisabet E. Manasanch, Victor Mulanovich, Joanna-Grace Manzano, Maria Susan Gaeta, Melody Becnel, Gregory P. Kaufman, et al. (+9)


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.010 sec